Testing an injection to prevent migraines after brain injury

This trial is testing whether Xeomin—an injectable medication—can help prevent migraines in people who have experienced a traumatic brain injury or a condition called anomalous health incidents (sometimes known as Havana syndrome). Researchers want to understand if this medication works equally well for both groups of patients. The study will enroll 60 people total across two groups.

Migraines are a very common problem after brain injuries, and current treatment options don't always work well enough for everyone. This medication has shown promise for preventing migraines in other situations, but researchers want to test whether it's effective specifically for people recovering from brain injuries or related health incidents.